when will retatrutide be released Retatrutide, a new weight loss drug not available on the market yet, is showing promising results in trials. @DrLaPook explains it's doing much more than what current medications can Eli Lilly's retatrutide shows promising

Contrave is an oral option that avoids needles, but its lower efficacy (5-9% weight loss) means treatment typically lasts longer than newer agents

Effect of 6-week course of glucagon-like peptide 1 on glycemic control, insulin sensitivity, and beta-cell function in type 2 diabetes: a parallel-group study

Overeating was a cue, weight was a symptom, a signal that we needed to pay attention

Instead, it helps reduce appetite, improve fullness, and support a calorie deficit, which encourages the body to use stored fat for energy over time

Semaglutide, Terzepatide, and Naltrexone/bupropion offer unique approaches to weight loss management